IAIM
COLL icon

International Assets Investment Management’s Collegium Pharmaceutical COLL Stock Holding History

International Assets Investment Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-800
Closed -$16K – 768
2021
Q1 		$16K Hold
800
– – ﹤0.01% 1378
2020
Q4 		$16K Buy
+800
New +$15.6K ﹤0.01% 1246

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

International Assets Investment Management's COLL Position: Q2 2021 in Review

International Assets Investment Management sold out of Collegium Pharmaceutical (COLL) in Q2 2021, closing a stake of 800 shares — an estimated $16K sold.

International Assets Investment Management first reported a position in COLL in Q4 2020 and held it in 2 quarters. The position peaked at $16K in Q1 2021. 158 funds tracked by Wall St. Rank hold COLL as of Q2 2021.

  • International Assets Investment Management reported no remaining Collegium Pharmaceutical position as of Q2 2021 after selling out during the quarter.
  • International Assets Investment Management sold 800 Collegium Pharmaceutical shares in Q2 2021, an estimated $16K.
  • International Assets Investment Management first reported a position in Collegium Pharmaceutical in Q4 2020 and held it in 2 quarters.
  • International Assets Investment Management's Collegium Pharmaceutical position peaked at $16K in Q1 2021.
  • 158 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2021.

Based on International Assets Investment Management's 13F filing for Q2 2021, filed 14 Jul 2021.